Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 141-150 of 9468

Page
per page
  1. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
     1 Citation
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC inhibitor
      ≥57.1 mg/mL
  2. Chlorambucil
    B3716 Chlorambucil
    Summary: nitrogen mustard alkylating agent
      insoluble in H2O; ≥12.15 mg/mL
  3. T-5224
    B4664 T-5224
     10 Citation
    Target: AP-1|MMP
    Summary: C-Fos/AP-1 inhibitor
      ≥25.88 mg/mL
  4. Bromocriptine mesylate
    B6298 Bromocriptine mesylate
    Summary: A potent, selective D2-like dopamine receptor agonist
      insoluble in H2O; insoluble in EtOH; ≥20.05 mg/mL
  5. (±)-Octanoylcarnitine chloride
    B6371 (±)-Octanoylcarnitine chloride
     5 Citation
    Summary: an intermediate in fatty acid metabolism
      ≥36.9 mg/mL
  6. POM 1
    B7153 POM 1
    Summary: A potent Ecto-NTPDase inhibitor
      ≥149.3 mg/mL
  7. Withaferin A
    B7199 Withaferin A
     2 Citation
    Summary: Prevents NF-κB activation by inhibiting activation of IKKβ
      Soluble in DMSO
  8. Sulprostone
    B7255 Sulprostone
    Summary: EP3 and EP1 receptor agonist
  9. Sodium acetate
    B7296 Sodium acetate
    Summary: Commonly used laboratory reagent
      ≥8.2 mg/mL
  10. Latrunculin A
    B7555 Latrunculin A
    Target: Actin
    Summary: Reversible inhibitor of actin assembly
      soluble in DMSO

Items 141-150 of 9468

Page
per page